Abstract and Introduction Review of Normal Platelet Physiology and Megakaryocytopoisis Qualitative Platelet Abnormalities Conclusion References Nitric oxide (NO) is another drug used in the neonatal ...

Thrombocytopenic disorders include numerous causes of decreased platelet production or increased platelet destruction. Having too few platelets can lead to internal or serious bleeding after surgery ...

Platelet disorders encompass a spectrum of inherited and acquired conditions in which the number, size or function of platelets is abnormal. The genetic basis of inherited platelet disorders ranges ...

Platelets play a central role in primary haemostasis by adhering to damaged endothelium, activating signalling cascades and aggregating to form a haemostatic plug. Platelet function disorders ...

Biomedical engineers report a new application for their synthetic platelets: treating the genetic condition that prevents blood from clotting, Von Willebrand disease (VWD). The most common of all ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...

Blood clotting depends on speed, force, and timing. Platelets have to stay quiet while circulating through the body, then ...

Agios gains global rights to cevidoplenib for ITP, adding a late-stage rare hematology asset with up to $1B U.S. peak sales ...

The prize is an oral spleen tyrosine kinase (SYK) inhibitor, called cevidoplenib, which has been developed by Korea’s Oscotec ...

Hemophilia, von Willebrand disease, anemia, leukemias, or a low platelet count can cause bruising. A person should contact a doctor if they are concerned about their bruising. Bruising is one of the ...

Even as biomedical engineer Anirban Sen Gupta refines artificial platelets to stem traumatic bleeding, he and his colleagues are seeking new uses for their synthetic solution. The latest application ...